The Patent Finder
US

Succinylcholine Prefilled Syringe, Compositions and Methods

US 11,779,535 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Jan 18, 2023 (Oxford Finance LLC).

Term ends Feb 11, 2039 · High confidence

Filed Jun 23, 2020 as application 16/909,340 · Granted Oct 10, 2023
Base term plus 643 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2019 2039
Clock starts
Feb 11, 2019
Term ends
Feb 11, 2039
Granted
Oct 10, 2023
base term Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
643
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,682,308, US 10,722,454, US 10,722,455.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 643 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 11, 2019, when application 16/272,815, the earliest non-provisional in its chain, was filed (this one was filed Jun 23, 2020)Feb 11, 2039High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+643 days, USPTO patent term adjustment recordNov 15, 2040High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,682,308, US 10,722,454, US 10,722,455)capped to Feb 11, 2039High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderFeb 11, 2039High confidence

This family

US 10,682,308In force
Feb 2039
Feb 2039
US 10,722,453In force
Feb 2039
Feb 2039
US 10,722,454In force
Feb 2039
Feb 2039
US 10,722,455In force
Feb 2039
Feb 2039
US 11,779,535this patent
Feb 2039
Feb 2039
US 12,194,141In force
Feb 2039
Feb 2039
Application 18/968,646Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 23, 2020
Reel 53014, frame 923
Soppimath, Kumaresh; Akasapu, Prem SagarNevakar, LLCAssignment of Assignor's Interest
Jun 23, 2020
Reel 53618, frame 24
Nevakar, LLCNevakar Inc.Change of Name
Aug 13, 2021
Reel 57183, frame 825
Nevakar Inc.Nevakar Injectables Inc.Assignment of Assignor's Interest
Jan 18, 2023
Reel 62405, frame 329
Nevakar Injectables Inc.Oxford Finance LLCSecurity Interest
May 4, 2023
Reel 63545, frame 646
Nevakar Injectables Inc.H.I.G. Bio - Nevakar, L.P.Patent Security Agreement
May 9, 2023
Reel 63583, frame 948
Nevakar Injectables Inc.Novaquest Co.-Investment Fund IX, L.P.Security Interest
May 9, 2023
Reel 63588, frame 122
Oxford Finance LLCNovaquest Co.-Investment Fund X, L.P.Security Interest
Sep 3, 2026
Reel 75902, frame 289
Novaquest Co.-Investment Fund IX, L.P.Nevakar Injectables Inc.Release of Security Interest
Sep 3, 2026
Reel 75902, frame 359
H.I.G. Bio - Nevakar, L.P.Nevakar Injectables Inc.Release of Security Interest
Sep 3, 2026
Reel 76340, frame 73
Novaquest Co.-Investment Fund X, L.P.Nevakar Inc.; Nevakar Injectables Inc.; Vyluma Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited